-DOCSTART- -X- O
BACKGROUND -X- _ O
: -X- _ O
On -X- _ O
the -X- _ O
30th -X- _ O
September -X- _ O
2009 -X- _ O
, -X- _ O
the -X- _ O
pandemic -X- _ B-Intervention
( -X- _ I-Intervention
H1N1 -X- _ I-Intervention
) -X- _ I-Intervention
2009 -X- _ I-Intervention
influenza -X- _ I-Intervention
vaccine -X- _ I-Intervention
was -X- _ O
made -X- _ O
available -X- _ O
to -X- _ O
adults -X- _ O
and -X- _ O
children -X- _ O
aged -X- _ O
10 -X- _ O
years -X- _ O
and -X- _ O
over -X- _ O
, -X- _ O
in -X- _ O
Australia. -X- _ O
Acceptance -X- _ O
of -X- _ O
a -X- _ O
novel -X- _ O
vaccine -X- _ O
is -X- _ O
influenced -X- _ O
by -X- _ O
perceptions -X- _ O
of -X- _ O
risk -X- _ O
including -X- _ O
risk -X- _ O
of -X- _ O
infection -X- _ O
, -X- _ O
risk -X- _ O
of -X- _ O
death -X- _ O
or -X- _ O
severe -X- _ O
illness -X- _ O
and -X- _ O
risk -X- _ O
of -X- _ O
serious -X- _ O
vaccine -X- _ O
side-effects. -X- _ O
We -X- _ O
surveyed -X- _ O
a -X- _ O
sample -X- _ O
of -X- _ O
residents -X- _ B-Patient
from -X- _ I-Patient
Sydney -X- _ I-Patient
, -X- _ I-Patient
Australia -X- _ I-Patient
to -X- _ O
ascertain -X- _ O
their -X- _ O
risk -X- _ B-Outcome
perception -X- _ I-Outcome
, -X- _ I-Outcome
attitudes -X- _ I-Outcome
towards -X- _ I-Outcome
the -X- _ I-Outcome
pandemic -X- _ I-Outcome
and -X- _ I-Outcome
willingness -X- _ I-Outcome
to -X- _ I-Outcome
accept -X- _ I-Outcome
the -X- _ I-Outcome
pandemic -X- _ I-Outcome
( -X- _ I-Outcome
H1N1 -X- _ I-Outcome
) -X- _ I-Outcome
2009 -X- _ I-Outcome
influenza -X- _ I-Outcome
vaccine. -X- _ I-Outcome
METHODS -X- _ O
: -X- _ O
We -X- _ O
sampled -X- _ O
residents -X- _ O
using -X- _ O
a -X- _ O
cross-sectional -X- _ O
intercept -X- _ O
design -X- _ O
during -X- _ O
the -X- _ O
WHO -X- _ O
Phase -X- _ O
6. -X- _ O
Members -X- _ O
of -X- _ O
the -X- _ O
public -X- _ O
were -X- _ O
approached -X- _ O
in -X- _ O
shopping -X- _ O
and -X- _ O
pedestrian -X- _ O
malls -X- _ O
to -X- _ O
undertake -X- _ O
the -X- _ O
survey -X- _ O
during -X- _ O
September -X- _ O
and -X- _ O
October -X- _ O
2009. -X- _ O
The -X- _ O
survey -X- _ O
measured -X- _ O
perceived -X- _ O
risk -X- _ O
, -X- _ O
seriousness -X- _ O
of -X- _ O
disease -X- _ O
, -X- _ O
recent -X- _ O
behavioural -X- _ O
changes -X- _ O
, -X- _ O
likely -X- _ O
acceptance -X- _ O
of -X- _ O
the -X- _ O
pandemic -X- _ B-Intervention
( -X- _ I-Intervention
H1N1 -X- _ I-Intervention
) -X- _ I-Intervention
2009 -X- _ I-Intervention
vaccine -X- _ I-Intervention
and -X- _ O
issues -X- _ O
relating -X- _ O
to -X- _ O
uptake -X- _ O
and -X- _ O
perceived -X- _ O
safety. -X- _ O
RESULTS -X- _ O
: -X- _ O
Of -X- _ O
the -X- _ O
627 -X- _ O
respondents -X- _ O
, -X- _ O
the -X- _ O
majority -X- _ B-Outcome
felt -X- _ I-Outcome
that -X- _ I-Outcome
they -X- _ I-Outcome
had -X- _ I-Outcome
a -X- _ I-Outcome
" -X- _ I-Outcome
very -X- _ I-Outcome
low -X- _ I-Outcome
to -X- _ I-Outcome
low -X- _ I-Outcome
" -X- _ I-Outcome
( -X- _ I-Outcome
332 -X- _ I-Outcome
/ -X- _ I-Outcome
627 -X- _ I-Outcome
, -X- _ I-Outcome
52.9 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
risk -X- _ I-Outcome
of -X- _ I-Outcome
acquiring -X- _ I-Outcome
H1N1. -X- _ I-Outcome
24.5 -X- _ I-Outcome
% -X- _ I-Outcome
( -X- _ I-Outcome
154 -X- _ I-Outcome
/ -X- _ I-Outcome
627 -X- _ I-Outcome
) -X- _ I-Outcome
of -X- _ I-Outcome
respondents -X- _ I-Outcome
believed -X- _ I-Outcome
that -X- _ I-Outcome
the -X- _ I-Outcome
disease -X- _ I-Outcome
would -X- _ I-Outcome
" -X- _ I-Outcome
very -X- _ I-Outcome
seriously -X- _ I-Outcome
or -X- _ I-Outcome
extremely -X- _ I-Outcome
" -X- _ I-Outcome
affect -X- _ I-Outcome
their -X- _ I-Outcome
health. -X- _ I-Outcome
Nearly -X- _ I-Outcome
half -X- _ I-Outcome
( -X- _ I-Outcome
305 -X- _ I-Outcome
/ -X- _ I-Outcome
627 -X- _ I-Outcome
, -X- _ I-Outcome
48.6 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
reported -X- _ I-Outcome
that -X- _ I-Outcome
in -X- _ I-Outcome
response -X- _ I-Outcome
to -X- _ I-Outcome
the -X- _ I-Outcome
" -X- _ I-Outcome
swine -X- _ I-Outcome
flu -X- _ I-Outcome
" -X- _ I-Outcome
outbreak -X- _ I-Outcome
they -X- _ I-Outcome
had -X- _ I-Outcome
undertaken -X- _ I-Outcome
one -X- _ I-Outcome
or -X- _ I-Outcome
more -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
investigated -X- _ I-Outcome
behavioural -X- _ I-Outcome
changes. -X- _ I-Outcome
Overall -X- _ I-Outcome
, -X- _ I-Outcome
the -X- _ I-Outcome
self-reported -X- _ I-Outcome
likelihood -X- _ I-Outcome
of -X- _ I-Outcome
accepting -X- _ I-Outcome
vaccination -X- _ I-Outcome
against -X- _ I-Outcome
novel -X- _ I-Outcome
H1N1 -X- _ I-Outcome
was -X- _ I-Outcome
54.7 -X- _ I-Outcome
% -X- _ I-Outcome
( -X- _ I-Outcome
343 -X- _ I-Outcome
/ -X- _ I-Outcome
627 -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ O
CONCLUSIONS -X- _ O
: -X- _ O
While -X- _ O
, -X- _ O
most -X- _ B-Outcome
participants -X- _ I-Outcome
did -X- _ I-Outcome
not -X- _ I-Outcome
believe -X- _ I-Outcome
they -X- _ I-Outcome
were -X- _ I-Outcome
at -X- _ I-Outcome
high -X- _ I-Outcome
risk -X- _ I-Outcome
of -X- _ I-Outcome
acquiring -X- _ I-Outcome
pandemic -X- _ I-Outcome
H1N1 -X- _ I-Outcome
2009 -X- _ I-Outcome
, -X- _ O
over -X- _ O
half -X- _ B-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
sample -X- _ I-Outcome
indicated -X- _ I-Outcome
that -X- _ I-Outcome
they -X- _ I-Outcome
would -X- _ I-Outcome
accept -X- _ I-Outcome
the -X- _ I-Outcome
vaccine. -X- _ I-Outcome
Participants -X- _ I-Outcome
who -X- _ I-Outcome
were -X- _ I-Outcome
vaccinated -X- _ I-Outcome
against -X- _ I-Outcome
the -X- _ I-Outcome
seasonal -X- _ I-Outcome
influenza -X- _ I-Outcome
were -X- _ I-Outcome
more -X- _ I-Outcome
likely -X- _ I-Outcome
to -X- _ I-Outcome
receive -X- _ I-Outcome
the -X- _ I-Outcome
H1N1 -X- _ I-Outcome
vaccine. -X- _ I-Outcome
Concerns -X- _ O
about -X- _ O
safety -X- _ O
, -X- _ O
the -X- _ O
possibility -X- _ O
of -X- _ O
side -X- _ O
effects -X- _ O
and -X- _ O
the -X- _ O
vaccine -X- _ O
development -X- _ O
process -X- _ O
need -X- _ O
to -X- _ O
be -X- _ O
addressed -X- _ O
. -X- _ O

